New constipation drug tested in young and elderly volunteers
NCT ID NCT01655771
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage study tested a single dose of TD-1211, an experimental drug for constipation, in 47 healthy adults split into younger (18-45) and older (65-85) groups. Researchers measured how the body absorbs and eliminates the drug and checked for side effects. The goal was to see if age affects drug safety and processing, not to test if it works for constipation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- TD-1211
- What this could lead to
- If successful, this study could help determine safe dosing of TD-1211 for constipation in different age groups.
- What could go wrong
- This is an early Phase 1 trial in healthy volunteers, not patients. It only measures safety and drug levels, not whether the drug works for constipation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONSTIPATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ICON Development Solutions
San Antonio, Texas, 78209, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could probiotics be the key to better digestion?
- Can a chicory fiber ease toddler constipation?
- Herbal blend and probiotics: a new hope for stubborn constipation?
- Can tiny ear needles unblock Post-Stroke constipation?
- Can bowel flushes reshape the Gut's bacterial landscape?
- Gut bacteria may hold the key to constipation relief